KraneShares Trust - KraneShares MSCI All China Health Care Index ETF Receivables

The latest receivables for KURE is $21M as of December 2017. That compares with $16M in the prior-year period — up 31.6% year over year. Investors often review this figure alongside KraneShares Trust - KraneShares MSCI All China Health Care Index ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, KURE's receivables moved from $16M to $21M — a 31.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in KraneShares Trust - KraneShares MSCI All China Health Care Index ETF's operating scale or balance-sheet position.

A receivables figure of $21M for KURE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KURE's receivables ($21M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.